SYNERGISTIC ACTIVITY OF DOXORUBICIN AND THE BISDIOXOPIPERAZINE (+)-1,2-BIS(3,5-DIOXOPIPERAZINYL-1-YL)PROPANE (ICRF 187) AGAINST THE MURINE SARCOMA S180 CELL-LINE

被引：0

作者：

WADLER, S ^{[1
]}

GREEN, MD ^{[1
]}

MUGGIA, FM ^{[1
]}

机构：

[1] NYU,SCH MED,DIV MED ONCOL,NEW YORK,NY 10016

来源：

CANCER RESEARCH | 1986年 / 46卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1176 / 1181

页数：6

共 33 条

[21] EFFECT OF [1,2-BIS(3,5-DIOXOPIPERAZIN-1-YL-PROPANE] (ICRF-159) ON PHARMACODYNAMICS OF DAUNOMYCIN
YESAIR, DW
SCHWARTZBACH, E
ASBELL, MA
WODINSKY, I
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1973, 14 (MAR): : 56 - +
[22] POTENTIATION OF DOXORUBICIN CYTOTOXICITY BY (+)-1,2-BIS-(3,5-DIOXOPIPERAZIN-1-YL) PROPANE (ICRF-187) IN HUMAN LEUKEMIC HL-60 CELLS
MONTI, E
SINHA, BK
CANCER COMMUNICATIONS, 1990, 2 (04): : 145 - 149
[23] EFFECT OF (+ OR -) 1,2-BIS(3,5-DIOXOPIPERAZIN-1-YL) PROPANE (ICRF 159) ON LIVER METASTASES FROM A HAMSTER LYMPHOMA
ATHERTON, A
EUROPEAN JOURNAL OF CANCER, 1975, 11 (06) : 383 - &
[24] EFFECTS OF AN ANTIMETASTATIC AGENT, (PLUS/MINUS)-1,2-BIS(3,5-DIOXOPIPERAZIN-1-YL)PROPANE(ICRF 159), ON PLATELET BEHAVIOR
ATHERTON, A
BUSFIELD, D
HELLMANN, K
CANCER RESEARCH, 1975, 35 (04) : 953 - 957
[25] ENHANCEMENT OF EXPERIMENTAL LUNG METASTASES BY CULTURED B-16 MELANOMA CELLS TREATED WITH (+/-)-1,2-BIS(3,5-DIOXOPIPERAZIN-1-YL)PROPANE (ICRF-159)
LAZO, JS
INGBER, DE
SARTORELLI, AC
CANCER RESEARCH, 1978, 38 (08) : 2263 - 2270
[26] PROTECTION BY (1,2,-BIS(3,5-DIOXOPIPERAZIN-1-YL)-PROPANE)(ICRF-159) AGAINST DAUNOMYCIN (DAU) TOXICITY AND ENHANCED ANTILEUKEMIC (1210) EFFICACY OF COMBINATION
WOODMAN, RJ
VENDITTI, JM
KLINE, I
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1972, 13 (MAR): : 31 - &
[27] AN UNEXPECTED HYDROLYSIS PH-RATE PROFILE, AT PH VALUES LESS THAN 7, OF THE LABILE IMIDE, ICRF-187 - (+)-1,2-BIS-(3,5-DIOXOPIPERAZIN-1-YL)PROPANE
SISCO, JM
STELLA, VJ
PHARMACEUTICAL RESEARCH, 1992, 9 (09) : 1209 - 1214
[28] EFFECTS OF THE L ISOMER (+)-1,2-BIS(3,5-DIOXOPIPERAZINE-1-YL)PROPANE ON CELL-SURVIVAL AND CELL-CYCLE PROGRESSION OF CULTURED MAMMALIAN-CELLS
TRAGANOS, F
DARZYNKIEWICZ, Z
MELAMED, MR
CANCER RESEARCH, 1981, 41 (11) : 4566 - 4576
[29] INVITRO EVIDENCE FOR DIRECT COMPLEXATION OF ADR-529/ICRF-187[(+)-1,2-BIS-(3,5-DIOXO-PIPERAZIN-1-YL)PROPANE] ONTO AN EXISTING FERRIC-ANTHRACYCLINE COMPLEX
SOBOL, MM
AMIET, RG
GREEN, MD
MOLECULAR PHARMACOLOGY, 1992, 41 (01) : 8 - 16
[30] DL-N,N'-DICARBOXAMIDOMETHYL-N,N'-DICARBOXYMETHYL-1,2-DIAMINOPROPANE (ICRF-198) AND D-1,2-BIS(3,5-DIOXOPIPERAZINE-1-YL)PROPANE (ICRF-187) INHIBITION OF FE-3+ REDUCTION, LIPID-PEROXIDATION, AND CAATPASE INACTIVATION IN HEART MICROSOMES EXPOSED TO ADRIAMYCIN
VILE, GF
WINTERBOURN, CC
CANCER RESEARCH, 1990, 50 (08) : 2307 - 2310

← 1 2 3 4 →